NEW YORK – Researchers at the University of Chicago, Bluestar Genomics, and elsewhere have developed a genome-wide tissue map of the DNA 5-hydroxymethylcytosine (5hmC) modification that revealed its role in tissue-specific development and as a potential diagnostic and prognostic biomarker for a variety of human diseases.